DrugPatentWatch Database Preview
Drugs in Development Information for Danoprevir
» See Plans and Pricing
What is the drug development status for Danoprevir?
Danoprevir is an investigational drug.
There have been 33 clinical trials for Danoprevir.
The most recent clinical trial was a Phase 2 trial, which was initiated on March 18th 2020.
The most common disease conditions in clinical trials are Hepatitis, Hepatitis C, Chronic, and Hepatitis C. The leading clinical trial sponsors are Hoffmann-La Roche, Ascletis Pharmaceuticals Co., Ltd., and Huoshenshan Hospital.
There are twenty-eight US patents protecting this investigational drug and five hundred and six international patents.
Summary for Danoprevir
| US Patents | 28 |
| International Patents | 506 |
| US Patent Applications | 48 |
| WIPO Patent Applications | 829 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2020-03-18) |
| Vendors | 43 |
Recent Clinical Trials for Danoprevir
| Title | Sponsor | Phase |
|---|---|---|
| Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection | Ascletis Pharmaceuticals Co., Ltd. | Phase 4 |
| Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection | Huoshenshan Hospital | Phase 4 |
| Evaluation of Ganovo Combined With Ritonavir in the Treatment of Novel Coronavirus Infection | Ascletis Pharmaceuticals Co., Ltd. | Phase 4 |
Clinical Trial Summary for Danoprevir
Top disease conditions for Danoprevir
Top clinical trial sponsors for Danoprevir
US Patents for Danoprevir
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Danoprevir | Start Trial | Method for treating HCV | AbbVie Inc. (North Chicago, IL) | Start Trial |
| Danoprevir | Start Trial | Macrocyclic compounds as inhibitors of viral replication | Intermune, Inc. (Brisbane, CA) | Start Trial |
| Danoprevir | Start Trial | Macrocyclic inhibitors of hepatitis C virus replication | InterMune, Inc. (Brisbane, CA) | Start Trial |
| Danoprevir | Start Trial | Process for the preparation of a macrocycle | Roche Palo Alto LLC (South San Francisco, CA) | Start Trial |
| Danoprevir | Start Trial | Ruthenium complexes as catalysts for metathesis reactions | Roche Palo Alto LLC (South San Francisco, CA) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Danoprevir
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Danoprevir | Australia | AU2014239563 | 2033-03-14 | Start Trial |
| Danoprevir | Australia | AU2015240754 | 2033-03-14 | Start Trial |
| Danoprevir | Australia | AU2016202823 | 2033-03-14 | Start Trial |
| Danoprevir | Australia | AU2016291154 | 2033-03-14 | Start Trial |
| Danoprevir | Australia | AU2017248487 | 2033-03-14 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
